Xeris Pharmaceuticals | XERS - Ebit





Ebit تغيير تاريخ
Celltrion KRW 13.41B 1.33B 2026-03
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -46.53M 23.01M 2026-03
Divis Laboratories Ltd INR 8.14B 420M 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Kangmei Pharma CNY -12.72M 13.97M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD -9.79M 10.33M 2026-03
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pharma Mar EUR 622K 42.99M 2026-03
Qiagen NV USD 96.88M 25M 2026-03
Sartorius EUR 164M 3.3M 2026-06
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03